Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathway

Fig. 5

The effects of celastrol on diabetes-induced inflammation and oxidative stress. (A–C) Quantification of ELISA assay of IL-1β, IL-6 and TNF-α. (D, E) Representative immunofluorescence staining of ROS and eNOS. Scale bar = 20 μm. (F, G) Relative quantification of ROS and eNOS. Data are shown as mean ± SD. n = 6, *P < 0.05 vs. Control; # P < 0.05 vs. DCM + celastrol.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us